137.40
Overview
News
Price History
Option Chain
Financials
Why A Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $137.40, with a volume of 2.92M.
It is up +1.74% in the last 24 hours and up +19.98% over the past month.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
See More
Previous Close:
$135.05
Open:
$134.22
24h Volume:
2.92M
Relative Volume:
1.29
Market Cap:
$38.81B
Revenue:
$7.23B
Net Income/Loss:
$1.41B
P/E Ratio:
27.60
EPS:
4.979
Net Cash Flow:
$1.09B
1W Performance:
+18.61%
1M Performance:
+19.98%
6M Performance:
-7.95%
1Y Performance:
+21.85%
Agilent Technologies Inc Stock (A) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
(408) 345-8886
Address
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
A
Agilent Technologies Inc
|
137.40 | 38.14B | 7.23B | 1.41B | 1.09B | 4.979 |
|
TMO
Thermo Fisher Scientific Inc
|
473.95 | 179.15B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
178.08 | 124.65B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
560.73 | 43.45B | 4.45B | 1.10B | 1.06B | 13.59 |
|
WAT
Waters Corp
|
379.77 | 36.52B | 3.77B | 449.25M | 240.68M | 7.8556 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Initiated | HSBC Securities | Buy |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-15-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Oct-08-25 | Upgrade | UBS | Neutral → Buy |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-17-23 | Downgrade | UBS | Buy → Neutral |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| May-24-23 | Reiterated | Barclays | Equal Weight |
| May-24-23 | Reiterated | BofA Securities | Buy |
| May-24-23 | Reiterated | Citigroup | Neutral |
| May-24-23 | Reiterated | Credit Suisse | Outperform |
| May-24-23 | Reiterated | Evercore ISI | Outperform |
| May-24-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-24-23 | Reiterated | Robert W. Baird | Outperform |
| May-24-23 | Reiterated | SVB Securities | Outperform |
| May-24-23 | Reiterated | Stifel | Hold |
| May-24-23 | Reiterated | TD Cowen | Outperform |
| May-24-23 | Reiterated | Wells Fargo | Overweight |
| May-11-23 | Initiated | Barclays | Equal Weight |
| Jan-10-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jul-08-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-22 | Reiterated | BofA Securities | Buy |
| Feb-23-22 | Reiterated | Citigroup | Buy |
| Feb-23-22 | Reiterated | Cowen | Outperform |
| Feb-23-22 | Reiterated | Evercore ISI | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-23-22 | Reiterated | Wells Fargo | Overweight |
| Nov-23-21 | Reiterated | BofA Securities | Buy |
| Nov-23-21 | Reiterated | Cowen | Outperform |
| Nov-23-21 | Reiterated | Stifel | Hold |
| Mar-18-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Upgrade | UBS | Neutral → Buy |
| Nov-17-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-30-20 | Initiated | Atlantic Equities | Neutral |
| Aug-19-20 | Reiterated | BofA Securities | Neutral |
| Aug-19-20 | Reiterated | Citigroup | Neutral |
| Aug-19-20 | Reiterated | Jefferies | Buy |
| Aug-19-20 | Reiterated | Robert W. Baird | Outperform |
| Aug-19-20 | Reiterated | SVB Leerink | Outperform |
| Aug-19-20 | Reiterated | Stifel | Hold |
| Aug-19-20 | Reiterated | Wells Fargo | Overweight |
| Feb-24-20 | Downgrade | Needham | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-26-19 | Reiterated | Needham | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | UBS | Buy → Neutral |
| Jul-16-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-15-19 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Agilent Technologies Inc Stock (A) Latest News
Why Agilent Technologies stock triumphed on Thursday - MSN
Agilent partners with OpenAI and BCG to embed AI across scientific instruments and operations - The Business Journals
Agilent Technologies Inc. stock (US00846U1016): Insider share sale follows FDA approval and guidance - AD HOC NEWS
Agilent stock is having its best day since 2002. Earnings leave Wall Street with ‘little to pick at.’ - MSN
HSBC Adjusts Price Target on Agilent Technologies to $165 From $180, Maintains Buy Rating - Moomoo
Agilent Technologies (A) Slid Over Investors’ Skepticism over Acquisition - Insider Monkey
Agilent Technologies (A) Declined in Q1 Amid QIAGEN Acquisition Speculation - Yahoo Finance
Agilent partners with OpenAI and BCG to deploy AI solutions By Investing.com - Investing.com Canada
Agilent partners with OpenAI and BCG to deploy AI solutions - Investing.com
Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation - The Joplin Globe
OpenAI joins Agilent lab tools in new push to speed up scientific discovery - Stock Titan
Agilent upgraded at BofA on FQ2 beats, growth - MSN
FDA approves Agilent’s PD-L1 test expansion for four cancers By Investing.com - Investing.com Nigeria
FDA approves Agilent’s PD-L1 test expansion for four cancers - Investing.com
FDA broadens cancer test to find more patients eligible for Keytruda - Stock Titan
Agilent (NYSE: A) director trims stake with 1,600-share stock sale - Stock Titan
Agilent introduces the 9500 Triple Quadrupole ICP-MS – Redefining trace element analysis - SelectScience
BofA Securities Adjusts Agilent Technologies PT to $155 From $145 - marketscreener.com
Is Now The Time To Look At Buying Agilent Technologies, Inc. (NYSE:A)? - Yahoo Finance
Agilent Technologies Q2 2026 Financial Report – Earnings, Revenue, and SEC Filing Highlights - Minichart
Agilent Q2 earnings call shows Ignite driving a higher outlook - MSN
Agilent Technologies Inc. stock (US00846U1016): shares advance after stronger Q2 2026 results and hi - AD HOC NEWS
Agilent presents its integrated mass spectrometry and chromatography solutions at ASMS 2026 - SelectScience
Agilent Technologies : and Sound Analytics Collaborate to Advance LC/MS Workflows for Drug Metabolism Research - marketscreener.com
Agilent Technologies 2Q 2026: Revenue $1.84B, EPS $1.2— 10-Q Summary - TradingView
Agilent (NYSE: A) posts profit growth, $950M Biocare deal and strong cash - Stock Titan
Jim Cramer on Agilent: “There Might Be an Opportunity” - Insider Monkey
Agilent Technologies Inc. stock (US00846U1016): shares in focus after recent earnings and analyst up - AD HOC NEWS
Agilent (A) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Agilent Technologies (A) Is Up 17.9% After Raising 2026 Outlook And Expanding Lab Informatics Portfolio - simplywall.st
Agilent launches new GC Systems to improve laboratory efficiency and data quality - BioSpectrum India
Agilent Q2 Earnings Call Shows Ignite Driving a Higher Outlook - Eastern Progress
Agilent Technologies, Inc. (A) Stock Analysis: Strong Buy Ratings and 19% Potential Upside Drive Investor Interest - DirectorsTalk Interviews
Agilent Technologies Opens with 16.54% Gain, Outperforming S&P 500's 0.58% Rise - Markets Mojo
Agilent Technologies Q2 earnings beat estimates, revenues up Y/Y - MSN
Agilent Technologies Inc. stock (US00846U1016): Technical picture in focus after recent trading cons - AD HOC NEWS
Is It Too Late To Consider Agilent Technologies (A) After Its Recent Share Price Surge - simplywall.st
Mettler-Toledo International vs Agilent Technologies: Which Is the Stronger Buy Today? - Trefis
7-Day Rally Sends Agilent Technologies Stock Up 23% - Trefis
Agilent Technologies Stock 7-Day Winning Spree: Stock Climbs 23% - Trefis
Stocks making big moves this week: Viasat, Agilent, Verra Mobility, Torrid, and Zscaler - Yahoo Finance
A (NYSE: A) files Form 144 notice listing 1,600 shares and vesting entries - Stock Titan
A Quick Look at Today's Ratings for Agilent Technologies(A.US), With a Forecast Between $145 to $170 - Moomoo
BofA Adjusts Price Target on Agilent Technologies to $145 From $150 - marketscreener.com
Agilent Technologies (A) Margin Gains Reinforce Bullish Recurring Revenue Narrative After Q2 2026 Results - simplywall.st
Agilent Technologies : Showcases Integrated Mass Spectrometry and Chromatography Solutions at ASMS 2026 - marketscreener.com
Agilent Technologies Stock (+17%): Q2 Earnings Beat and Raised FY26 Guidance - Trefis
Stock Market Today: S&P 500, Dow Futures Inch Up As US-Iran Deal Awaits Trump Approval — Dell, Agilent, Hewlett Packard Enterprise In Focus - Benzinga
Top Agilent Technologies (A) Competitors 2026 - MarketBeat
Agilent Technologies Stock Surges 22%, With A 6-Day Winning Spree - Trefis
Agilent Technologies Stock Rockets 22% With 6-Day Winning Streak - Trefis
Agilent Technologies Inc Stock (A) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):